Stem cell therapy for knees is a procedure in which cells are collected — usually from your own bone marrow or fat — and injected into the knee joint, most often with the goal of easing osteoarthritis pain. It is not a standard treatment. No major orthopedic or rheumatology organization currently recommends it as routine care for knee arthritis, and the evidence that it works is mixed. It is widely marketed, frequently expensive, and rarely covered by insurance.
What Is Stem Cell Therapy For Knees And Does It Work?
The honest answer is that it depends on what you mean by “work,” and the evidence is not strong enough to promise anyone a result.
Most clinics offering this treatment use your own tissue. The two common sources are bone marrow, drawn from the back of your hip, and fat, collected by liposuction. The sample is processed to concentrate cells, then injected into the knee. A smaller number of clinics use donor cells from another person or cells grown in a lab.
What gets injected is not purely stem cells. Bone marrow aspirate concentrate contains a mix of cells, including mesenchymal stem cells, plus platelets, growth factors, and other signaling molecules. How many actual stem cells end up in the syringe varies widely between clinics and between patients.
The marketing often says these cells will rebuild cartilage. That claim runs ahead of the evidence. Cartilage has very limited ability to heal, and no study has shown that knee injections regrow worn cartilage in humans in a reliable, measurable way.
What Does the Evidence Actually Show?
Research on this topic is real, but it is limited in ways that matter. Most studies are small, follow patients for only months rather than years, and use different cell sources, different doses, and different processing methods. That makes it hard to compare results or draw firm conclusions.
Some studies suggest people with knee osteoarthritis report less pain after these injections. Whether that improvement is meaningful and lasting is where the uncertainty lives. Placebo responses in knee injection studies are notoriously large, which means a portion of reported relief may come from the expectation of relief rather than the cells themselves.
Some injections trigger a temporary inflammatory reaction. Patients often report more pain and swelling for a few days before any improvement, and some mistake this flare for the treatment failing. It is a known response, not a sign the procedure did not take.
What the evidence does not support is the idea that this is a proven alternative to knee replacement. For advanced arthritis with significant cartilage loss, no stem cell injection has been shown to restore the joint.
Is Stem Cell Therapy for Knees Approved by the FDA?
This is where a lot of confusion lives, and it is worth getting straight.
The FDA has not approved any stem cell product for the treatment of knee osteoarthritis. There is no approved stem cell injection for knees in the United States.
What exists is a regulatory gray zone. Clinics that harvest a patient’s own cells, process them minimally, and reinject them in the same surgical session often operate under a framework that treats this as the practice of medicine rather than the manufacture of a drug. That is a different thing from FDA approval. It means the product has not been reviewed for safety and effectiveness the way a drug or device would be.
Clinics that grow cells in culture, use donor cells, or make broader claims cross into territory the FDA considers unapproved drug manufacturing. The agency has issued warnings and taken action against some clinics for this. If a clinic tells you its treatment is “FDA approved,” that statement is inaccurate.
What Are the Risks and Downsides?
The short-term risks are those of any knee injection plus those of the harvest site. They include pain, swelling, bleeding, and infection. Infection in a joint is uncommon but serious and requires prompt treatment.
Harvesting bone marrow involves a needle into the hip bone. Harvesting fat involves liposuction, which carries its own recovery. Neither is trivial.
The longer-term risks are genuinely uncertain. That uncertainty is not a reason to panic, but it is a reason for honesty. When cells are expanded in a lab and then injected, there are theoretical concerns about unwanted tissue formation, though this has not been clearly documented in knee joint injections. When donor cells are used, there are immune and disease-transmission considerations.
The most concrete downside may be financial. These procedures commonly cost thousands of dollars out of pocket, and insurance generally does not cover them. If the relief does not last, that money is gone, and the knee arthritis is still there.
How Does It Compare to Other Knee Treatments?
It helps to see where stem cell injections sit next to options that have stronger evidence behind them.
| Treatment | Evidence for knee osteoarthritis | Typical coverage |
|---|---|---|
| Exercise and physical therapy | Strong | Often covered |
| Weight management | Strong for reducing load and symptoms | Not a procedure |
| NSAIDs and pain relievers | Established for symptom relief | Covered |
| Corticosteroid injections | Established for short-term relief | Covered |
| Hyaluronic acid injections | Mixed; benefit is modest at best | Variably covered |
| Platelet-rich plasma (PRP) | Mixed; some studies show modest benefit | Usually not covered |
| Stem cell injections | Limited and mixed | Generally not covered |
| Knee replacement | Established for advanced disease | Covered |
Notice the pattern. The treatments with the strongest evidence are not the ones being marketed hardest. Exercise, physical therapy, and weight management consistently show benefit for knee osteoarthritis, and they carry the least risk. They are also the least exciting to sell.
Platelet-rich plasma deserves a mention because it is often bundled with or confused with stem cell therapy. PRP uses concentrated platelets from your own blood. Some studies suggest it may modestly reduce pain in knee arthritis, but results vary and it is not established as a standard treatment either.
Why Is the Marketing So Aggressive?
Knee osteoarthritis is common, painful, and frustrating. People want to avoid or delay surgery, and they want something that feels like a real fix rather than another round of pain pills. That combination creates a market.
Stem cells carry cultural weight. The word suggests regeneration and renewal, and that framing does a lot of work in advertising. It is easy to imply more than the data supports without technically lying.
Watch for these patterns. Claims that the treatment “regrows cartilage” or “cures arthritis.” Testimonials instead of study data. Prices that vary wildly between clinics. A vague explanation of where the cells come from. Pressure to decide quickly. Any of these should slow you down.
None of this means every clinic is acting in bad faith. Some are run by physicians who believe in the approach and are trying to help. Good intentions, though, are not the same as proven benefit.
What Should You Ask Before Considering It?
If you are thinking about this, get clear answers first. A clinic that cannot answer these questions plainly is telling you something.
- Where do the cells come from — my own tissue, or a donor?
- Are the cells processed or grown in a lab, or used the same day?
- What is the actual evidence this will help my specific knee?
- What are the total costs, and is any of it covered by insurance?
- What happens if it does not work?
- Is the person performing the injection a board-certified physician, and in what specialty?
It is also reasonable to ask your own doctor or a sports medicine or orthopedic specialist for an opinion before spending money. They can review your imaging and tell you whether you are a candidate for treatments with stronger evidence.
One clarification worth holding onto. A treatment being biologically plausible is not the same as a treatment being proven to work. The idea that stem cells could help a knee makes sense on paper. Whether they do, in a way that reliably helps patients, is still an open question.
Frequently Asked Questions
Does stem cell therapy for knees actually regrow cartilage?
No study has shown that knee stem cell injections reliably regrow worn cartilage in humans. Some clinics claim this, but the evidence does not support it.
Is stem cell therapy for knees FDA approved?
No. The FDA has not approved any stem cell product for treating knee osteoarthritis in the United States.
How long does stem cell therapy for knees last?
There is no established answer, because studies vary widely and few follow patients long enough to say. Any specific duration you see advertised is not backed by solid evidence.
Does insurance cover stem cell injections for knees?
Generally no. Most insurers classify these injections as experimental or investigational, so patients usually pay out of pocket.
